Low-Dose Cyclosporine Combined with Eltrombopag in Patients with Primary Immune Thrombocytopenia Refractory or Dependent to First-Line Glucocorticoid Treatment (ChiCTR) - Oct 16, 2026 - P=N/A | N=94 | Not yet recruiting | Sponsor: The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine); The First Affiliated Hospital
New trial • Hematological Disorders • Immune Thrombocytopenic Purpura • Thrombocytopenia • Thrombocytopenic Purpura
|